Taro Pharmaceutical Industries Ltd
General ticker "TARO" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $1.6B
Taro Pharmaceutical Industries Ltd follows the US Stock Market performance with the rate: 55.2%.
Estimated limits based on current volatility of 0.1%: low 42.82$, high 42.95$
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term predictions were made for the period from 2024-03-31 to 2026-03-31
- 2024-03-31 to 2025-03-31 predicted range: [34.74$, 54.37$]
- 2025-03-31 to 2026-03-31 predicted range: [31.97$, 52.27$]
Financial Metrics affecting the TARO estimates:
- Positive: 0.96 < Non-GAAP EPS of 1.75
- Positive: 1.56 < Operating Cash Flow per share of 3.52
- Positive: 0.04 < Industry Earnings per Price (median) of 0.05
- Positive: 0.01 < Operating Income to Revenue ratio of 0.03
- Positive: 0 < Net Income to Assets ratio of 0.02
Short-term TARO quotes
Long-term TARO plot with estimates
Financial data
| YTD | 2023-03-31 | 2024-03-31 |
|---|---|---|
| Operating Revenue | $572.95MM | $629.18MM |
| Operating Expenses | $555.24MM | $607.67MM |
| Operating Income | $17.71MM | $21.51MM |
| Non-Operating Income | $20.50MM | $61.16MM |
| Interest Expense | $17.69MM | $0.00MM |
| R&D Expense | $52.24MM | $64.54MM |
| Income(Loss) | $38.21MM | $82.67MM |
| Taxes | $12.77MM | $28.80MM |
| Profit(Loss) | $25.45MM | $53.87MM |
| Stockholders Equity | $1,730.86MM | $1,793.01MM |
| Assets | $2,135.51MM | $2,162.07MM |
| Operating Cash Flow | $31.75MM | $132.39MM |
| Investing Cash Flow | $-125.56MM | $84.34MM |
| Earnings Per Share* | $0.68 | $1.43 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.